AKYA - Akoya Biosciences Operating income before deduction of amortization
Akoya Biosciences operates on a "razor-and-blade" model, where system sales lock customers into purchasing consumables. Cash operating profit demonstrates the resilience of a business protected by reagent patents. Constant demand for cartridges ensures a steady cash flow, and serves as the final mark for this financial metric.
Akoya Biosciences, Inc. (AKYA) - metric breakdowns and financial figures
- current price and projected stock value:
- market capitalization statistics:
- balance sheet equity data:
- business debt structure and liquidity details:
Total Debt to Equity Ratio Akoya Biosciences|AKYA - Long-Term Debt to Capital|Current Liabilities to Capital Akoya Biosciences Inc|AKYA - Company Aggregate Debts|Debt to Book Value Ratio Akoya Biosciences|AKYA - Company Long-Term Debts|Short-Term Debt Volume Akoya Biosciences|Quick Liquidity Indicator akoyabio.com
- earnings and multiples data:
AKYA - Net Profit|Projected Future Earnings Akoya Biosciences|AKYA - Price to Earnings Ratio|Future Price to Earnings Akoya Biosciences Inc|AKYA - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Akoya Biosciences|AKYA - Operating profit EBITDA|Net earnings per one share for the last twelve months Akoya Biosciences|AKYA - Earnings per share for the last twelve months|Net earnings per share growth for the trailing year akoyabio.com|AKYA - Net earnings per share growth this year|Earnings growth forecast for next year Akoya Biosciences
Summary company analytics:Akoya Biosciences - AKYA
This indicator reflects the net cash result from core operations before depreciation and interest, allowing for an assessment of the actual scale of cash generation. For Akoya Biosciences (AKYA), this process is fueled by high customer loyalty to consumables, which makes the company's total operating profit an indicator of ecosystem resilience and confirms the high value of its technological assets.
Who Akoya Biosciences competes with
Company profit before taxes, interest and amortization ABT (Abbott Corp.)|Thermo Fisher Scientific - Operating profit EBITDA|Operating income before deduction of amortization gehealthcare.com GEHC|MTD: Operating profit EBITDA|Operating profit before deduction of amortization Waters Corp|Operating profit before deduction of amortization TECH|BRKR: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Azenta, Inc. (AZTA)|Operating profit before deduction of amortization vareximaging.com VREX|Operating profit EBITDA SMLR (Semler Scientific)|Butterfly Network Inc (BFLY) - Profit before interest, taxes and amortization|Mesa Labs Corp - Operating profit EBITDA|QSI (Quantum-Si Corporation) - Operating profit before amortization|NNOX: Operating profit EBITDA|QTRX - Operating income before deduction of amortization|MASS (908 Devices) - Operating profit EBITDA|Operating profit before deduction of amortization CapsoVision Medical (CV)|Operating profit EBITDA MXCT|Operating profit EBITDA rapidmicrobio.com (RPID)|Profit before payment of interest, taxes and amortization Seer, Inc. SEER|hyperfine.io - Profit before payment of interest, taxes and amortization|FONR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization DXR (Daxor Corporation)|MDAI: Operating profit EBITDA|Profit before interest, taxes and amortization Organovo Holdings Inc. (VIVS)|Profit before payment of interest, taxes and amortization Aclarion|THMO - Operating profit before depreciation charges|Operating profit before deduction of amortization TLIS (Talis Biomedical)|Operating profit EBITDA T2 Biosystems Inc. (TTOO)
